Science

Nita Radhakrishnan: Cost analysis of thalassemia screening vs treatment in different health care sectors

Nita Radhakrishnan/LinkedIn

Mar 26, 2025, 14:03

Nita Radhakrishnan: Cost analysis of thalassemia screening vs treatment in different health care sectors

Nita Radhakrishnan, Associate Professor and Head of the Department of Pediatric Hematology-Oncology at the Post-Graduate Institute of Child Health, shared an article by Ritu Gupta, et al. on X:

“Cost analysis of thalassemia screening vs treatment in different health care sectors – Work done by our team Ped Hem Onc PGI Child Health, Noida, India Post Graduate Institute of Child Health, Noida with Prof Shomik Ray‘s group Public Health Foundation of India (PHFI).

Screening for thalassemia trait is crucial for our country.”

Comparative Analysis of the Cost of Thalassemia Screening VS Treatment in Different Healthcare Sectors in Delhi National Capital Region.

Authors: Ritu Gupta, et al.

Nita Radhakrishnan: Cost analysis of thalassemia screening vs treatment in different health care sectors

cancer fight against cancer Global fight against cancer healthcare sectors Nita Radhakrishnan OncoDaily Oncology Ped Hem Onc PGI Child Health Pediatric Hematology PHFI Post Graduate Institute of Child Health Public Health Foundation of India Shomik Ray thalassemia

April is Head and Neck Cancer Awareness Month

Is Cancer Hereditary? Myths and Facts about Cancer Genetics

Neuroendocrine Lung Tumors: Types, Symptoms, Diagnosis, Treatment and 2025 updates

Cancer Center Near Me: Dana-Farber Cancer Institute

FDA Approves Nivolumab and Ipilimumab for First-Line Treatment of Unresectable Hepatocellular Carcinoma Based on CheckMate-9DW Trial